C83.77

Clinical Causes: Genetic mutations leading to the uncontrolled growth of B-lymphocytes (a type of white blood cell). Infections, such as Epstein-Barr virus (EBV), which has been linked to certain types of Burkitt lymphoma. Immunodeficiency states, including HIV/AIDS, which impair the immune system's ability to control abnormal cell growth. Environmental factors, though specific links are still under research, may include exposure to certain chemicals or radiation. Family history of lymphoma or other cancers, indicating genetic predispositions may play a role.

Key Symptoms: Swelling or a lump in the upper left abdomen caused by spleen enlargement. Abdominal pain or discomfort. Unexplained weight loss. Fever or night sweats without obvious infection. Fatigue and weakness. Possible symptoms related to the spread of cancer to other parts of the body, such as lymph nodes or bones.

Diagnosis Path: Diagnosing Burkitt lymphoma of the spleen typically involves a combination of clinical evaluation, imaging tests, and laboratory procedures: - **Physical Examination:** Checking for abdominal swelling or tenderness. - **Imaging Tests:** Ultrasound, CT scans, or MRI scans to visualize spleen enlargement and determine the extent of disease. - **Laboratory Tests:** Blood counts and blood chemistry profiles to assess overall health. - **Biopsy:** The definitive diagnosis is made through a biopsy of the spleen or affected lymph nodes, where tissue is examined microscopically for characteristic cancer cells. - **Flow Cytometry and Molecular Tests:** These may be performed on biopsy samples to identify specific cellular markers and genetic abnormalities associated with Burkitt lymphoma.

Treatment Protocols: Treatment strategies for Burkitt lymphoma of the spleen usually involve aggressive chemotherapy regimens tailored to the patient's overall health and disease stage. Common approaches include: - **Chemotherapy:** Intensive regimens such as the CODOX-M/IVAC protocol are often used to target rapidly dividing cancer cells. - **Targeted Therapy:** Depending on genetic features, therapies targeting specific molecules or pathways may be considered. - **Immunotherapy:** Emerging treatments that help the immune system recognize and attack lymphoma cells. - **Supportive Care:** Managing side effects, preventing infections, and maintaining overall health during treatment. - **Radiation Therapy:** Less commonly used but may be considered in certain cases. Multidisciplinary care is essential, encompassing oncologists, hematologists, and supportive care teams to optimize outcomes.